Opioid maker Purdue reaches $8bn settlement to end probe
Purdue formally admitted to criminal conduct related to distribution of its painkillers and agreed to pay $225m to resolve US justice department investigations
21 October 2020 - 20:03
New York — Purdue Pharma agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with US prosecutors that stopped short of criminally charging its executives or wealthy Sackler family owners.
In a far-reaching agreement unveiled on Wednesday, Purdue formally admitted to criminal conduct related to distribution of its painkillers and agreed to pay $225m to resolve US justice department investigations. Prosecutors imposed significant penalties exceeding $8bn against Purdue, though the lion's share will go largely unpaid...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.